[1] |
Wieland E, Olbricht CJ, Süsal C, et al. Bio-markers as a tool for management of immunosuppression in transplant patients[J]. Ther Drug Monit, 2010, 32(5):560-572. doi: 10.1097/FTD.0b013e3181efb3d2
|
[2] |
Barraclough KA, Staatz CE, Isbel NM, et al. Review: pharmacodynamic monitoring of immunosuppression in kidney transplantation[J]. Nephrology, 2010, 15(5):522-532. doi: 10.1111/j.1440-1797.2010.01349.x
|
[3] |
Louis S, Audrain M, Cantarovich D, et al. Long-term cell monitoring of kidney recipients after an antilymphocyte globulin induction with and without steroids[J]. Transplantation,2007, 83(6):712-721. doi: 10.1097/01.tp.0000255683.66156.d3
|
[4] |
李龙,戚贵生,杨橙,等.全身淋巴照射联合ATG在致敏患者肾移植及逆转AMR中的应用[J].中华器官移植杂志,2013,34(4):209-213.
Li L, Qi GS, Yang C, et al. Application of combined TLI and low-dose ATG in highly sensitized or AMR renal allograft recipients: clinical practice and mechanism exploration[J]. Chin Organ Transplant,2013,34(4):209-213.
|
[5] |
Ducloux D, Courivaud C, Bamoulid J, et al. Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation[J]. J Am Soc Nephrol,2010,21(5):868-875. doi: 10.1681/ASN.2009090976
|
[6] |
刘宝阳,张磊,戈海泽,等.大鼠肝移植术后肝脏T淋巴细胞凋亡与免疫耐受的关系[J].器官移植,2012,3(4):213-218. http://www.organtranspl.com/browse/detail/qkid/59/id/611.html
Liu BY, Zhang L, Ge HY, et al. Relationship between immune tolerance and hepatic T lymphocytes apoptosis after liver transplantation in rats[J]. Organ Transplant, 2012,3(4):213-218. http://www.organtranspl.com/browse/detail/qkid/59/id/611.html
|
[7] |
Jankowski MM, Ignatowska-Jankowska B, Glac W, et al. Cocaine administration increases CD4/CD8 lymphocyte ratio in peripheral blood despite lymphopenia and elevated corticosterone[J]. Int Immunopharmacol,2010,10(10):1229-1234. doi: 10.1016/j.intimp.2010.07.003
|
[8] |
Wahlin BE, Sundstr m C, Holte H, et al. T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab[J]. Clin Cancer Res,2011,17(12):4136-4144. doi: 10.1158/1078-0432.CCR-11-0264
|
[9] |
Li Y, Guo Z, Liu CF, et al. Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+ CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma[J]. Cryobiology,2012,65(1):56-59. doi: 10.1016/j.cryobiol.2012.04.002
|
[10] |
Liu Z, Fan H, Jiang S. CD4(+) T-cell subsets in transplantation[J]. Immunol Rev,2013,252(1):183-191. doi: 10.1111/imr.12038
|
[11] |
Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells[J]. Immunity,2006,25(2):195-201. doi: 10.1016/j.immuni.2006.08.003
|
[12] |
Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease[J]. Immunol Rev,2006,212:8-27. doi: 10.1111/imr.2006.212.issue-1
|
[13] |
Strioga M, Pasukoniene V, Characiejus D. CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease[J]. Immunology,2011,134(1):17-32. doi: 10.1111/imm.2011.134.issue-1
|
[14] |
Fan H, Cao P, Game DS, et al. Regulatory T cell therapy for the induction of clinical organ transplantation tolerance[J]. Semin Immunol,2011,23(6):453-461. doi: 10.1016/j.smim.2011.08.012
|
[15] |
Baan C, Bouvy A, Vafadari R, et al. Phospho-specific flow cytometry for pharmacodynamic monitoring of immunosuppressive therapy in transplantation[J]. Transplant Res,2012,1(1):20. doi: 10.1186/2047-1440-1-20
|
[16] |
Demmers MW, Baan CC, Janssen M, et al. Substantial proliferation of human renal tubular epithelial cell-reactive CD4+CD28null memory T cells, which is resistant to tacrolimus and everolimus[J]. Transplantation,2014,97(1):47-55. doi: 10.1097/01.TP.0000435697.31148.b2
|
[17] |
Couzi L, Thiébaut R, Carron JC, et al. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients[J]. Transplantation,2008,86(8):1060-1067. doi: 10.1097/TP.0b013e31818758e4
|
[18] |
Zachary AA, Leffell MS. Barriers to successful transplantation of the sensitized patient[J]. Expert Rev Clin Immunol,2010,6(3):449-460. doi: 10.1586/eci.10.14
|
[19] |
Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay[J]. Transplantation,2006,82(5):663-668. doi: 10.1097/01.tp.0000234837.02126.70
|
[20] |
Rodrigo E, López-Hoyos M, Corral M, et al. ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis[J]. Liver Transpl,2012,18(10):1245-1253. http://cn.bing.com/academic/profile?id=2010256207&encoded=0&v=paper_preview&mkt=zh-cn
|
[21] |
Israeli M, Klein T, Sredni B, et al. ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients[J]. Liver Transpl,2008,14(6):893-898. doi: 10.1002/(ISSN)1527-6473
|
[22] |
Huskey J, Gralla J, Wiseman AC. Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection[J]. Clin J Am Soc Nephrol,2011,6(2):423-429. doi: 10.2215/CJN.04210510
|
[23] |
Torío A, Fernández EJ, Montes-Ares O, et al. Lack of association of immune cell function test with rejection in kidney transplantation[J]. Transplant Proc,2011,43(6):2168-2170. doi: 10.1016/j.transproceed.2011.06.056
|
[24] |
Martinez OM, Villanueva J, Abtahi S, et al. CD30 expression identifies a functional alloreactive human T-lymphocyte subset[J]. Transplantation,1998,65(9):1240-1247. doi: 10.1097/00007890-199805150-00016
|
[25] |
Gaspal FM, Kim MY, McConnell FM, et al. Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory[J]. J Immunol,2005,174(7):3891-3896. doi: 10.4049/jimmunol.174.7.3891
|
[26] |
Dai Z, Li Q, Wang Y, et al. CD4+ CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism[J]. J Clin Invest,2004,113(2):310-317. doi: 10.1172/JCI19727
|
[27] |
Chen Y, Tai Q, Hong S, et al. Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis[J]. Transplantation,2012,94(9):911-918. doi: 10.1097/TP.0b013e31826784ad
|
[28] |
Velásquez SY, García LF, Opelz G, et al. Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-γ and IL-2[J]. Transplantation,2013,96(2):154-161. doi: 10.1097/TP.0b013e318296fd69
|
[29] |
Fernández-Ruiz M, López-Medrano F, Varela-Peña P, et al. Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection[J]. Am J Transplant,2012,12(10):2763-2773. doi: 10.1111/j.1600-6143.2012.04192.x
|
[30] |
Cretel E, Touchard D, Bongrand P, et al. A new method for rapid detection of T lymphocyte decision to proliferate after encountering activating surfaces[J]. J Immunol Methods,2011,364(1/2):33-39.
|
[31] |
Bestard O, Crespo E, Stein M, et al. Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients[J]. Am J Transplant,2013,13(7):1880-1890. doi: 10.1111/ajt.12285
|
[32] |
Sommerer C, Konstandin M, Dengler T, et al. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies[J]. Transplantation,2006,82(10):1280-1285. doi: 10.1097/01.tp.0000243358.75863.57
|
[33] |
Kalluri HV, Hardinger KL. Current state of renal transplant immunosuppression: Present and future[J]. World J Transplant,2012,2(4):51-68. doi: 10.5500/wjt.v2.i4.51
|
[34] |
Hartmann B, He X, Keller F, et al. Development of a sensitive phospho-p70 S6 kinase ELISA to quantify mTOR proliferation signal inhibition[J]. Ther Drug Monit,2013,35(2):233-239. doi: 10.1097/FTD.0b013e3182804c9b
|
[35] |
Kaltenborn A, Schrem H. Mycophenolate mofetil in liver transplantation: a review[J]. Ann Transplant,2013,18:685-696. doi: 10.12659/AOT.889299
|
[36] |
Glander P, Sombogaard F, Budde K, et al. Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells[J]. Ther Drug Monit,2009,31(3):351-359. doi: 10.1097/FTD.0b013e31819c3f3d
|
[37] |
Fernández-Ruiz M, López-Medrano F, Varela-Peña P, et al. Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection[J]. Am J Transplant,2012,12(10):2763-2773. doi: 10.1111/j.1600-6143.2012.04192.x
|
[38] |
Li RD, Sun Z, Dong JY, et al. A quantitative assessment model of T-cell immune function for predicting risks of infection and rejection during the early stage after liver transplantation[J]. Clin Transplant,2013,27(5):666-672. http://cn.bing.com/academic/profile?id=2007436860&encoded=0&v=paper_preview&mkt=zh-cn
|
[39] |
Israeli M, Yussim A, Mor E, et al. Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform[J]. Transpl Immunol,2007,18(1):7-12. doi: 10.1016/j.trim.2007.03.005
|